Biological characteristics of gene-manipulated mice for carcinogenicity test (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)

スポンサーリンク

概要

著者

関連論文

ラット大腸における異常陰窩巣形成ならびにrasH2マウスにおける大腸発癌に対するヨーグルトの抑制効果
Decontamination of Human Xenotransplantable Tumor with Mouse Hepatitis Virus by Implantation in Nude Rat: A Case Report
Quarantine for Contaminated Pathogens in Transplantable Human Tumors or Infections in Tumor Bearing Mice
Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
Chemotherapeutic Profiles of Human Tumors Implanted in SCID Mice Showing Appreciable Inconsistencies with Those in Nude Mice
"C-7 A Rapid Carcinogenicity Test in Transgenic Mice Carrying Human c-Ha-ras Gene.
The in vivo development of human T cells from CD34^+ cells in the murine thymic environment
EXAMINATION OF PERCUTANEOUS APPLICATION IN A 26-WEEK CARCINOGENICITY TEST IN CB6F1-TG rasH2 MICE
A rapid carcinogenicity testing system using transgenic mice harboring human prototype c-Ha-ras gene
Induction of Drug Metabolism-Related Enzymes by Methylcholanthrene and Phenobarbital in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene and Their Wild Type Littermates
Leukocyte Differential Analysis in Multiple Laboratory Species by a Laser Multi-Angle Polarized Light Scattering Separation Method
ANALYSIS OF ABNORMALITY OF CORTICOHISTOGENESIS IN THE REELER MUTANT MICE BY PRODUCING CHIMERA MICE : ABSENCE OF ABNORMALITY IN NEURONS IN THE REELER (Contribution of Histochemistry to Developmental Neurobiology)
A Humanized anti-c-erbB-2 Monoclonal Antibody for the Treatment of Breast Cancer
Use of IC tags in short-term carcinogenicity studies on CB6F1-TgrasH2 mice(Carcinogenicity, Proceedings of the 32nd Annual Meeting)
P8-31 Effect of vehicles for a dermal carcinogenicity testing of CB6F1-TgrasH2 mice(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
P6-41 Comparative study on the carcinogenicity of phenolphthalein in rasH2 and p53 knockout mice(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
Influence of the administration route and the vehicle on CB6F1-TgrasH2 mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Background data of human prototype c-Ha-ras transgenic (CB6Fl-TgrasH2) mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Biological characteristics of gene-manipulated mice for carcinogenicity test (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
USE OF IC TAGS IN SHORT-TERM CARCINOGENICITY STUDY ON CB6F1 TGrasH2 MICE
C57BL/6JJclを遺伝的背景に持つIRS2欠損マウスの効率的な繁殖方法の検討
Inhibitory Effect of Apple Pectin and Culture Condensate of Bifidobacterium Iongum of Colorectal Tumors Induced by 1,2-Dimethylhydrazine in Transgenic Mice Harboring Human Prototype c-Ha-ras Genes
Effect of Mouse Intestinal Bacteria on Incidence of Colorectal Tumors Induced by 1, 2-dimethylhydrazine Injection in Gnotobiotic Transgenic Mice Harboring Human Prototype c-Ha-ras Genes
Conversion of the Genetic Background of Transgenic Mice by In Vitro Fertilization
The Creation of Mouse Models for Human Diseases Associated with Reproductive Disturbances by In Vitro Fertilization and Embryo Transfer
P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting)
22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.
21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity.
P-46 Differences in immunotoxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 weeks.(Proceedings of the 27th Annual Meeting)
Report 1 : TESTING FOR CARCINOGENICITY OF PHARMACEUTICALS : S1, A ; Conditions which require carcinogenicity studies for pharmaceuticals S1, B ; Use of two rodent species S1, C ; Dose selection for carcinogenicity studies of pharmaceuticals (CA
Aberrant Expression of Cyclin D1 in Pulmonary Proliferative Lesions Induced by High Doses of Urethane in Transgenic Mice Carrying the Human Prototype c-H-ras Gene
Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
HETEROTRANSPLANTATION OF HUMAN NEOPLASMS IN NUDE MICE
MONOASSOCIATION WITH BACTERIA IN THE INTESTINES OF GERMFREE MICE

もっと見る

スポンサーリンク